Concepedia

Jiangsong Jiang

JJ

4

Publications

281

Citations

4

H-Index

2017

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Jiangsong Jiang is an author at Center for Drug Evaluation and Research specializing in breast cancer, medicine, and pharmacology.

Top concepts

Publications per year

2017–2019

4

Publications

4

Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers

Nishant Mohan, Jiangsong Jiang, Milos Dokmanovic et al. · Antibody Therapeutics · 2018 · 150 citations · Full text

, , +15

Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1<sup>+</sup>triple negative breast cancer cells

Nishant Mohan, Salman B. Hosain, Jun Zhao et al. · OncoImmunology · 2019 · 70 citations · Full text

Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity

Jiangsong Jiang, Nishant Mohan, Yukinori Endo et al. · Oncotarget · 2017 · 34 citations · Full text

, , +19

Payload of T-DM1 binds to cell surface cytoskeleton-associated protein 5 to mediate cytotoxicity of hepatocytes

Yukinori Endo, Kazuyo Takeda, Nishant Mohan et al. · Oncotarget · 2018 · 27 citations · Full text

Rows per page

1–4 of 4